Added to YB: 2025-10-16
Pitch date: 2025-10-14
MYX.AX [neutral]
Mayne Pharma Group Limited
-41.96%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
Market Cap
AUD 501.3M
Pitch Price
AUD 5.60
Price Target
7.40 (+128%)
Dividend
N/A
EV/EBITDA
9.68
P/E
-5.41
EV/Sales
1.08
Sector
Pharmaceuticals
Category
special_situation
Two Cases Waiting on a $$$ Verdict - Mayne Pharma Group Limited
MYX.AX (legal special sit): Mayne Pharma in court drama as Cosette tries escaping $7.40/share acquisition via MAC clause - untested in Australian law. Despite legal uncertainty, fundamentals improved: 5% revenue growth to $408.1M, 460% operating cash flow surge, new PBS contraceptive approval. Binary outcome imminent.
Read full article (2 min)